The Experimental Study of Mongolian Medicine Digeda-4powder for TAA Induced Chemical Liver Lesion of Mice

GAO Yu-feng,BA Gen-na,QING Yu
DOI: https://doi.org/10.3969/j.issn.1006-6810.2009.05.023
2010-01-01
Abstract:Objective:To observe the protection and treatment action of Digeda-4powder for TAA induced liver lesion of mice.Methods: Digeda-4powder group and Huganpian group should be given respectively intragastric administration 7 days,acute liver lesion of mice was induced by peritoneal injection TAA 80mg·kg-1,twenty four hours after,to get blood sample,to separate serum,to detect activity of serum ALT,AST; to get hepatic tissue and to observe the hepatic morphological change.Results:Digeda-4powder decrease obviosly the serum ALT and AST of TAA induced liver lesion mice (P0.01). The change of model groups hepatic tissues show the piecemeal necrosis;the positive control groups hepatic tissues show scattered punctiform and dimin piecemeal necrosis;the Digeda-4powder groups hepatic tissues show scattered punctiform and dimin piecemeal necrosis;also it is infiltrated phlegmonosis cell.Conclusion: Digeda-4powder has protection and treatment action on the above mentioned TAA induced liver lesion models to some extent.
What problem does this paper attempt to address?